Zur Bedeutung des SNP309 des Mdm2-Gens für die CVID und die rheumatoide Arthritis

作者: Monika Barbara Müller

DOI: 10.22028/D291-21149

关键词:

摘要: A single nucleotide polymorphism (exchange of a base) in the prormoter region Mdm2 gene (SNP309) was first described 2004. It shown that change from Thymine to Guanine at position 309 intron caused higher affinity promoter for transcription factor Sp1. Thus is facilitated. well known as one most important negative regulators tumor suppressor p53. Accordingly, an increased synthesis suppresses cellular p53 signalling. The consequence is, DNA-damaged cells are less efficiently repaired or eliminated and thus more prone development. In addition serves antagonist NfκB, determining course inflammations. P53 suppression therefore causes sensitive reaction towards inflammatory reaction. We asked whether by SNP309 could be associated with development chronic inflammations, especially inflammations linked activity NfκB. Rheumatoid Arthritis lymphadenophathy, splenomegaly granulomatous disease patients CVID (common variable immunodeficiency) were chosen examples such diseases. First genotype distribution among Europeans analysed. results obtained, failed differ those North Americans group discovered (p = 0,299). 52 0,743) showed also no difference compared healthy Europeans. Similarly association lymphadenopathy 0,282), 0,806) 0,422) detectable. Interestingly, often detected people (healthy people: G/T 49,3 %, G/G 14,2 %; RA: 42,2 10,9 p= 0,046). Gender-dependent stratification differences female 0,043). No between distributions males 0,577). Increased Mdm2-levels might

参考文章(53)
Zhibin Hu, Hongxia Ma, Daru Lu, Ji Qian, Jiannong Zhou, Yijiang Chen, Lin Xu, Xinru Wang, Qingyi Wei, Hongbing Shen, Genetic variants in the MDM2 promoter and lung cancer risk in a Chinese population International Journal of Cancer. ,vol. 118, pp. 1275- 1278 ,(2006) , 10.1002/IJC.21463
Naoki Ohmiya, Ayumu Taguchi, Nobuyuki Mabuchi, Akihiro Itoh, Yoshiki Hirooka, Yasumasa Niwa, Hidemi Goto, MDM2 Promoter Polymorphism Is Associated With Both an Increased Susceptibility to Gastric Carcinoma and Poor Prognosis Journal of Clinical Oncology. ,vol. 24, pp. 4434- 4440 ,(2006) , 10.1200/JCO.2005.04.1459
M Inazuka, T Tahira, T Horiuchi, S Harashima, T Sawabe, M Kondo, H Miyahara, K Hayashi, Analysis of p53 tumour suppressor gene somatic mutations in rheumatoid arthritis synovium Rheumatology. ,vol. 39, pp. 262- 266 ,(2000) , 10.1093/RHEUMATOLOGY/39.3.262
Ute M. Moll, Oleksi Petrenko, The MDM2-p53 Interaction Molecular Cancer Research. ,vol. 1, pp. 1001- 1008 ,(2003)
Marjanka K Schmidt, Scarlett Reincke, Annegien Broeks, Linde M Braaf, Frans BL Hogervorst, Rob AEM Tollenaar, Nichola Johnson, Olivia Fletcher, Julian Peto, Johanna Tommiska, Carl Blomqvist, Heli A Nevanlinna, Catherine S Healey, Alison M Dunning, Paul DP Pharoah, Douglas F Easton, Thilo Dörk, Laura J Van't Veer, Breast Cancer Association Consortium, Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium. Cancer Research. ,vol. 67, pp. 9584- 9590 ,(2007) , 10.1158/0008-5472.CAN-07-0738
Tomoo Iwakuma, Guillermina Lozano, MDM2, An Introduction Molecular Cancer Research. ,vol. 1, pp. 993- 1000 ,(2003)
Steele, Thompson, Hall, Lane, The p53 tumour suppressor gene British Journal of Surgery. ,vol. 85, pp. 1460- 1467 ,(2003) , 10.1046/J.1365-2168.1998.00910.X
Marijke Wasielewski, Jord H. A. Nagel, Cecile Brekelmans, Jan G. M. Klijn, Ans van den Ouweland, Hanne Meijers-Heijboer, Mieke Schutte, MDM2 SNP309 accelerates familial breast carcinogenesis independently of estrogen signaling Breast Cancer Research and Treatment. ,vol. 104, pp. 153- 157 ,(2007) , 10.1007/S10549-006-9407-5
Frank Kullmann, Martin Judex, Ingrid Neudecker, Sandra Lechner, Hans-Peter J�sten, Douglas R. Green, Dieter Wessinghage, Gary S. Firestein, Steffen Gay, J�rgen Sch�lmerich, Ulf M�ller-Ladner, Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts. Arthritis & Rheumatism. ,vol. 42, pp. 1594- 1600 ,(1999) , 10.1002/1529-0131(199908)42:8<1594::AID-ANR5>3.0.CO;2-#